In complex diseases, such as cancer and viral infection, multiple signaling pathways or mechanisms are involved. For cancer treatments, combinations of two therapeutic antibodies with different mechanisms of action have been shown to be more effective than individual monotherapy.
At Alphamab Oncology, we have developed two proprietary technical approaches to provide innovative solutions to address this growing need in the development of modern biotherapeutics.
